|
John F. DeBernardis Ph.D. has been President and Chief Executive Officer of the Company since August 1999. He joined the Company in August 1993 as Director of Chemistry and Pharmacology was promoted to Vice President of Discovery and Senior Vice President Research and Development. He was Secretary of the Company from April 1995 to August 1999 and was appointed a director of the Company in November 1995. Prior to joining the Company Dr. DeBernardis spent sixteen years at Abbott Laboratories where he began his career as a research chemist and progressively earned several promotions ending with his position as the Area Head of Cardiovascular Research within the Pharmaceutical Products Division supervising an 85 person staff. During his tenure a number of IND candidates were identified. Dr. DeBernardis received his Ph.D. degree from the University of Pittsburgh in 1974 and worked two years as an NIH postdoctoral fellow in the Department of Chemistry at MIT. He is co-author on 70 scientific publications and holds 35 U.S. patents. | 